FREE Webinar

Thursday, March 25, 2021
9:00 - 11:00 Eastern Time (2:00 - 4:00 PM CET)

Register Now

The COVID-19 pandemic necessitates rapid research to characterize SARS-CoV-2, understand host-pathogen interactions, and develop functional vaccines and therapeutics. Scientists working on this problem use innovative technologies to study molecular interactions essential for viral infection, which then guides drug and vaccine development. In this webinar sponsored by Sartorius, Dmitri Svergun, Pedro Beltrao, and Christian Loew will discuss how they fast-track COVID-19 virology research by identifying molecular targets and assessing their structure and function for antiviral therapies.

Topics to be covered

  • Studying the cellular processes targeted by SARS-CoV-2 to identify potential antiviral drugs
  • Structural analysis of COVID-19-related molecules by small-angle X-ray scattering
  • Selection and structural analysis of synthetic nanobodies that effectively neutralize SARS-CoV-2

Register Now

Meet the speakers

Pedro Beltrao, PhD
Group Leader
European Molecular Biology Laboratory (EMBL)
European Bioinformatics Institute (EMBL-EBI)
Wellcome Genome...

Dmitri Svergun, PhD
Group Leader and Senior Scientist
European Molecular Biology Laboratory (EMBL), Hamburg Unit
Deutsches Elektronen Synchrotron (DESY)

Christian Löw, PhD
Group Leader
European Molecular Biology Laboratory (EMBL), Hamburg Unit
Deutsches Elektronen Synchrotron (DESY)

Interested in reading more?

The Scientist ARCHIVES

Become a Member of

Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member?